{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "health-sciences:medicine:rheumatology:rheum-037",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-09T01:57:26.000Z",
    "contributors": [
      "copilot-agent"
    ],
    "confidence": 0.9,
    "status": "validated"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/rheumatology",
    "type": "procedure",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "title": "JAK Inhibitors",
    "summary": "Small molecule DMARDs",
    "key_points": [
      "Tofacitinib, baricitinib",
      "Oral administration",
      "VTE and cardiovascular risks"
    ]
  },
  "prerequisites": [],
  "related_concepts": [],
  "evidence": {
    "citations": [],
    "confidence_rationale": "Standard medical knowledge"
  },
  "learning_objectives": [
    "Understand JAK Inhibitors"
  ],
  "clinical_pearls": [
    "Tofacitinib, baricitinib"
  ]
}